Sedarat Z, Taylor-Robinson A
Pathogens. 2024; 13(5).
PMID: 38787244
PMC: 11124246.
DOI: 10.3390/pathogens13050392.
Sijmons D, Guy A, Walduck A, Ramsland P
Front Immunol. 2022; 13:868225.
PMID: 35634347
PMC: 9136243.
DOI: 10.3389/fimmu.2022.868225.
Saxena A, Mukhopadhyay A, Nandi S
J Biosci. 2020; 45.
PMID: 32975237
PMC: 7481552.
Mandalasi M, Dorabawila N, Smith D, Heimburg-Molinaro J, Cummings R, Nyame A
Glycobiology. 2013; 23(7):877-92.
PMID: 23542315
PMC: 3671776.
DOI: 10.1093/glycob/cwt025.
Kajiwara H, Toda M, Mine T, Nakada H, Yamamoto T
Microbes Environ. 2012; 27(4):515-8.
PMID: 23100020
PMC: 4103564.
DOI: 10.1264/jsme2.me12058.
Genotypic and phenotypic variation of Lewis antigen expression in geographically diverse Helicobacter pylori isolates.
Pohl M, Zhang W, Shah S, Sanabria-Valentin E, Perez-Perez G, Blaser M
Helicobacter. 2011; 16(6):475-81.
PMID: 22059399
PMC: 3228314.
DOI: 10.1111/j.1523-5378.2011.00897.x.
Cancer vaccines and carbohydrate epitopes.
Heimburg-Molinaro J, Lum M, Vijay G, Jain M, Almogren A, Rittenhouse-Olson K
Vaccine. 2011; 29(48):8802-26.
PMID: 21964054
PMC: 3208265.
DOI: 10.1016/j.vaccine.2011.09.009.
Fucosylation and gastrointestinal cancer.
Moriwaki K, Miyoshi E
World J Hepatol. 2010; 2(4):151-61.
PMID: 21160988
PMC: 2999278.
DOI: 10.4254/wjh.v2.i4.151.
Helicobacter pylori lipopolysaccharide is synthesized via a novel pathway with an evolutionary connection to protein N-glycosylation.
Hug I, Couturier M, Rooker M, Taylor D, Stein M, Feldman M
PLoS Pathog. 2010; 6(3):e1000819.
PMID: 20333251
PMC: 2841628.
DOI: 10.1371/journal.ppat.1000819.
Helicobacter pylori lipopolysaccharide modification, Lewis antigen expression, and gastric colonization are cholesterol-dependent.
Hildebrandt E, McGee D
BMC Microbiol. 2009; 9:258.
PMID: 20003432
PMC: 2804598.
DOI: 10.1186/1471-2180-9-258.
Population-associated differences between the phase variable LPS biosynthetic genes of Helicobacter pylori.
Salaun L, Saunders N
BMC Microbiol. 2006; 6:79.
PMID: 16981984
PMC: 1599737.
DOI: 10.1186/1471-2180-6-79.
Host Lewis phenotype-dependent Helicobacter pylori Lewis antigen expression in rhesus monkeys.
Wirth H, Yang M, Sanabria-Valentin E, Berg D, Dubois A, Blaser M
FASEB J. 2006; 20(9):1534-6.
PMID: 16720729
PMC: 2579782.
DOI: 10.1096/fj.05-5529fje.
The Helicobacter pylori flaA1 and wbpB genes control lipopolysaccharide and flagellum synthesis and function.
Merkx-Jacques A, Obhi R, Bethune G, Creuzenet C
J Bacteriol. 2004; 186(8):2253-65.
PMID: 15060026
PMC: 412133.
DOI: 10.1128/JB.186.8.2253-2265.2004.
Host gastric Lewis expression determines the bacterial density of Helicobacter pylori in babA2 genopositive infection.
Sheu B, Sheu S, Yang H, Huang A, Wu J
Gut. 2003; 52(7):927-32.
PMID: 12801945
PMC: 1773709.
DOI: 10.1136/gut.52.7.927.
Relationship of anti-Lewis x and anti-Lewis y antibodies in serum samples from gastric cancer and chronic gastritis patients to Helicobacter pylori-mediated autoimmunity.
Heneghan M, McCarthy C, Janulaityte D, Moran A
Infect Immun. 2001; 69(8):4774-81.
PMID: 11447150
PMC: 98564.
DOI: 10.1128/IAI.69.8.4774-4781.2001.
Emergence of diverse Helicobacter species in the pathogenesis of gastric and enterohepatic diseases.
Solnick J, Schauer D
Clin Microbiol Rev. 2001; 14(1):59-97.
PMID: 11148003
PMC: 88962.
DOI: 10.1128/CMR.14.1.59-97.2001.
Comparative genomics of Helicobacter pylori: analysis of the outer membrane protein families.
Alm R, Bina J, Andrews B, Doig P, Hancock R, Trust T
Infect Immun. 2000; 68(7):4155-68.
PMID: 10858232
PMC: 101716.
DOI: 10.1128/IAI.68.7.4155-4168.2000.
Quasispecies development of Helicobacter pylori observed in paired isolates obtained years apart from the same host.
Kuipers E, Israel D, Kusters J, Gerrits M, Weel J, van der Ende A
J Infect Dis. 1999; 181(1):273-82.
PMID: 10608776
PMC: 2766531.
DOI: 10.1086/315173.
Two distinct antigenic types of the polysaccharide chains of Helicobacter pylori lipopolysaccharides characterized by reactivity with sera from humans with natural infection.
Yokota S, Amano K, Shibata Y, Nakajima M, Suzuki M, Hayashi S
Infect Immun. 1999; 68(1):151-9.
PMID: 10603381
PMC: 97114.
DOI: 10.1128/IAI.68.1.151-159.2000.
Soluble platelet selectin (sP-selectin) and soluble vascular cell adhesion molecule-1 (sVCAM-1) decrease during therapy with benznidazole in children with indeterminate form of Chagas' disease.
Laucella S, Segura E, Riarte A, Sosa E
Clin Exp Immunol. 1999; 118(3):423-7.
PMID: 10594562
PMC: 1905450.
DOI: 10.1046/j.1365-2249.1999.01070.x.